Markerless Motion Capture to Quantify Functional Performance in Neurodegeneration: Systematic Review
JMIR Aging · 2024-08-06 · 7 · e52582
DOI: 10.2196/52582 ↗At a glance
Systematische Übersicht in JMIR Aging, published online on 2024-08-06. Written by Julian Jeyasingh-Jacob and 7 co-authors. Institution: Department of Brain Sciences, Imperial College London, London, United Kingdom. Major MEDLINE topics: Cognitive Dysfunction, Motion Capture. Cited 25 times so far (Crossref); 49 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Markerless motion capture (MMC) uses video cameras or depth sensors for full body tracking and presents a promising approach for objectively and unobtrusively monitoring functional performance within community settings, to aid clinical decision-making in neurodegenerative diseases such as dementia.
Objective
The primary objective of this systematic review was to investigate the application of MMC using full-body tracking, to quantify functional performance in people with dementia, mild cognitive impairment, and Parkinson disease.
Methods
A systematic search of the Embase, MEDLINE, CINAHL, and Scopus databases was conducted between November 2022 and February 2023, which yielded a total of 1595 results. The inclusion criteria were MMC and full-body tracking. A total of 157 studies were included for full-text screening, out of which 26 eligible studies that met the selection criteria were included in the review.
Results
Primarily, the selected studies focused on gait analysis (n=24), while other functional tasks, such as sit to stand (n=5) and stepping in place (n=1), were also explored. However, activities of daily living were not evaluated in any of the included studies. MMC models varied across the studies, encompassing depth cameras (n=18) versus standard video cameras (n=5) or mobile phone cameras (n=2) with postprocessing using deep learning models. However, only 6 studies conducted rigorous comparisons with established gold-standard motion capture models.
Conclusions
Despite its potential as an effective tool for analyzing movement and posture in individuals with dementia, mild cognitive impairment, and Parkinson disease, further research is required to establish the clinical usefulness of MMC in quantifying mobility and functional performance in the real world.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Brain Sciences, Imperial College London, London, United Kingdom.
- Care Research and Technology Centre, UK Dementia Research Institute, Imperial College London, London, United Kingdom.
- Department of Basic and Clinical Neuroscience, King's College London, London, United Kingdom.
ORCID profiles: Julian Jeyasingh-Jacob, Mark Crook-Rumsey, Harshvi Shah, Theresita Joseph, Subati Abulikemu, Sarah Daniels, David J Sharp, Shlomi Haar
Cite
APA
Jeyasingh-Jacob, J., Crook-Rumsey, M., Shah, H., Joseph, T., Abulikemu, S., Daniels, S., Sharp, D. J., & Haar, S. (2024). Markerless Motion Capture to Quantify Functional Performance in Neurodegeneration: Systematic Review. JMIR Aging, 7, e52582. https://doi.org/10.2196/52582
Vancouver
Jeyasingh-Jacob J, Crook-Rumsey M, Shah H, Joseph T, Abulikemu S, Daniels S, et al. Markerless Motion Capture to Quantify Functional Performance in Neurodegeneration: Systematic Review. JMIR Aging. 2024;7:e52582. doi:10.2196/52582
BibTeX
@article{JeyasinghJacob2024,
author = {Jeyasingh-Jacob, Julian and Crook-Rumsey, Mark and Shah, Harshvi and Joseph, Theresita and Abulikemu, Subati and Daniels, Sarah and Sharp, David J and Haar, Shlomi},
title = {Markerless Motion Capture to Quantify Functional Performance in Neurodegeneration: Systematic Review},
journal = {JMIR Aging},
year = {2024},
volume = {7},
pages = {e52582},
doi = {10.2196/52582}
}
EUVIMED